As part of efforts to improve the nation's long-term supply of influenza vaccine, the federal government is launching a clinical trial to help get a German-made vaccine licensed for regular use in the United States.
(CIDRAP News) By recreating a key surface protein from the 1918 pandemic flu virus and testing its effects in mice, researchers have shown that the protein might have been an important reason for the virus's extraordinary ability to kill.
(CIDRAP News) The federal government announced this week it is launching a campaign to map the genetic blueprint of thousands of human and avian influenza viruses in an effort to better understand how flu viruses evolve, spread, and cause disease.
(CIDRAP News) Clinical trials of a vaccine designed to keep the H5N1 avian influenza virus from sparking a human flu pandemic will begin early in 2005, the head of the National Institute of Allergy and Infectious Diseases (NIAID) said this week.
(CIDRAP News) – The outbreak of H5N1 avian influenza in Asia gives the world its first opportunity to prepare a vaccine in advance for a potential pandemic strain of flu, the World Health Organization (WHO) said today as it convened a meeting of vaccine companies and health officials to consider the challenge.
Editor's note: A correction was made in this story Nov 9 to note that the existing licensed anthrax vaccine contains the natural rather than recombinant form of anthrax protective antigen.
(CIDRAP News) Federal health officials today announced the award of an $877 million contract for 75 million doses of a new anthrax vaccine to protect the public and improve on the existing vaccine used by the military.
(CIDRAP News) Two studies just published by the New England Journal of Medicine (NEJM) suggest that injecting influenza vaccine just beneath the skin surface, instead of into muscle, may be a way to stretch flu vaccine supplies without sacrificing protection.
(CIDRAP News) The National Institute of Allergy and Infectious Diseases (NIAID) has awarded contracts worth more than $73 million to study the mechanisms by which certain infectious agents, including potential bioterror agents, trigger immune reactions, the National Institutes of Health (NIH) announced yesterday.
(CIDRAP News) Federal researchers report they have succeeded in infecting monkeys with fatal smallpox, creating the first animal model of the disease for use in testing vaccines and treatments for humans.